ANN ARBOR, Mich., March 13, 2019 (GLOBE NEWSWIRE) — Esperion (NASDAQ:ESPR) announced that results from the 2,230 patient, 52-week, Phase 3 long-term safety study of bempedoic acid (CLEAR Harmony, also known as Study 1 or 1002-040) were published today in The New England Journal of Medicine (NEJM). Bempedoic acid is being […]
Other News
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) — Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced its financial results for the year ended December 31, 2018, and recent business highlights. “We are looking forward to […]
Correvio Reports Fourth Quarter and Full Year 2018 Financial Results
Company on Track to Resubmit Brinavess NDA in Q2 2019 Mark H.N. Corrigan, MD to Commence CEO Duties on March 14, 2019 Management to Host Conference Call and Webcast Today, March 13, 2019 at 8:00 a.m. Eastern (5:00 a.m. Pacific) NASDAQ: CORV TSX: CORV VANCOUVER, March 13, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical […]
Neovasc to Announce Year Ended December 31, 2018 Financial Results on Thursday, March 21
Conference Call Scheduled for 4:30pm Eastern Time NASDAQ, TSX: NVCN VANCOUVER, March 13, 2019 /PRNewswire/ – Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today […]
Boston Scientific Receives CE Mark for Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device
MARLBOROUGH, Mass., March 13, 2019 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) announced it has received CE Mark and initiated a limited market release of the next generation WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device in Europe. Patients with AF are five times more likely to suffer a stroke than someone with a normal heart […]
Bay Labs’ New Studies at ACC.19 Demo Accuracy, Efficiency and Reproducibility of its AI Software
SAN FRANCISCO – March 13, 2019 – Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, today announced the presentation of two studies assessing performance of the company’s deep learning software. The first evaluated the company’s software when used by medical professionals […]
Proximo Medical Announces New Client Win With EMBA
CASTLE PINES, Colo., March 13, 2019 /PRNewswire/ — Proximo Medical today announced that it has been selected as the marketing and commercialization partner of choice for EMBA Medical™ Limited, a medical device company that designs and develops peripheral embolization technologies focused on improving safety, control, and outcomes. Proximo Medical, a revenue-accelerating, risk-sharing, reduced-cost approach to […]
Bay Labs Announces New Data that Evaluates Accuracy, Efficiency and Reproducibility of EchoGPS™ and AutoEF AI Software
Bay Labs Announces New Data that Evaluates Accuracy, Efficiency and Reproducibility of EchoGPS™ and AutoEF AI Software Results Presented at the American College of Cardiology ACC.19 68th Annual Scientific Session SAN FRANCISCO – March 13, 2019 – Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) […]
Sotera Wireless to Showcase Newest ViSi Mobile® 1.5G Capability at AONE Conference in April
SAN DIEGO–(BUSINESS WIRE)–Sotera Wireless, maker of the ViSi Mobile® Surveillance Monitoring System and a pioneer in continuous vital signs monitoring, announced it will be exhibiting at the American Organization of Nurse Executives (AONE), the leading voice of nursing leadership in health care. The 4-day event brings nurse leaders together to […]
Corindus Vascular Robotics Announces Additional Closing of Private Placement
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced the execution of an additional closing of the private placement previously announced on February 26, 2019. In the additional closing, existing investors with preemptive rights purchased an aggregate […]



